Abstract
In accordance to their functions, most cells from the innate immune system are equipped with multiple receptors that sense invading pathogens and endogenous danger signals resultant from damaged cells. Recognition of such “alarm signals” triggers complex signaling pathways that involve the recruitment of adapter molecules to the receptors and consequent activation of transducers such as protein kinases. Finally, these cascades culminate in the nuclear translocation of transcription factors that control the expression of inflammatory effector molecules like cytokines, chemokines and enzymes involved in oxidative burst and prostaglandin/leukotriene synthesis. Also, Natural Killer (NK) cells, a particular type of inate immune cells, express multiple activating and inhibitory receptors that act in concert to capacitate them to directly recognize and destroy transformed or viraly infected cells, to secrete cytokines or both. The knowledge on these intricate signaling networks is crucial for the comprehension of the physiopathology of inflammatory diseases as well as for identification of possible therapeutical targets. In this chapter we provide an overview of the transduction cascades triggered following danger sensing by innate immune cells, as well as examples evidencing the impact of their malfunction to human health.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ADCC:
-
Antibody-dependent cellular cytotoxicity
- AICL:
-
Activation-induced C-type lectin
- AIM:
-
Absent-in-melanoma
- Akt:
-
Protein kinase B
- ALR:
-
AIM-like receptors
- AMP:
-
Adenosine monophosphate
- AP-1:
-
Activator protein 1
- ASC:
-
Apoptosis-associated speck-like protein containing CARD
- ATP:
-
Adenosine triphosphate
- BCG:
-
Bacillus Calmette-Guérin
- Bcl:
-
B cell lymphoma
- BDCA:
-
Blood dendritic cell antigen
- BIR:
-
Baculovirus inhibitor repeat
- c-Abl:
-
Abelson tyrosine kinase
- CARD:
-
Caspase recruitment domain protein
- CBP:
-
CREB-binding protein
- CCL:
-
C-C motif chemokine ligand
- CD:
-
Cluster of differentiation
- Cdc42:
-
Cell division cycle 42
- cGAMP:
-
Cyclic-GMP-AMP
- cGAS:
-
cGAMP synthase
- CLEC:
-
C-type lectin-like receptors
- CLR:
-
C-type lectin receptors
- CpG ODN:
-
CpG oligodeoxynucleotides
- CRACC:
-
CD2-like receptor activating cytotoxic cells
- CRD:
-
Carbohydrate recognition domain
- CREB:
-
cAMP response element binding
- CTLD:
-
C-type lectin-like domain
- DAI:
-
DNA-dependent activator of interferon-regulatory factors
- DAMPs:
-
Damage-associated molecular patterns
- DAP10, 12:
-
DNAX activating proteins of 10 kDa, 12 kDa
- DC:
-
Dendritic cell
- DCAL-2:
-
Dendritic cell-associated C-type lectin 2
- DCIR:
-
DC-immunoreceptor
- DC-SIGN:
-
DC-specific intercellular adhesion molecule (ICAM)-3 grabbing nonintegrin
- DDX:
-
DEAD-box helicase 41
- DDX60:
-
DExD/H-box helicase 60
- Dectin:
-
DC-associated C-type lectin-1
- DHX:
-
DExH-box helicase 9
- DHX36:
-
DEAH-box helicase 36
- DNA:
-
Deoxyribonucleic acid
- DNAM-1:
-
DNAX accessory molecule-1
- DNAPK:
-
DNA-dependent protein kinase
- dsDNA:
-
Double stranded DNA
- dsRNA:
-
Double stranded RNA
- EAT-2:
-
Ewing’s sarcoma-associated transcript-2
- EBV:
-
Epstein-Barr vírus
- ER:
-
Endoplasmic reticulum
- ERK:
-
Extracellular signal-regulated kinase
- FADD:
-
Fas-associated protein with death domain
- FcRγ:
-
Fc receptor γ chain
- GM-CSF:
-
Granulocyte and macrophage colony stimulating factor
- GMP:
-
Guanosine monophosphate
- Grb2:
-
Growth factor receptor-bound protein 2
- HIN:
-
Hematopoietic interferon-inducible nuclear antigens
- HIV-1:
-
Human immunodeficiency virus 1
- HLA:
-
Human leukocyte antigen
- HMGB1:
-
High-mobility group box 1
- hMGL:
-
Human Monoglyceride lipase
- HMGN1:
-
High Mobility Group Nucleosome Binding Domain 1
- HSPs:
-
Heat-shock proteins
- ICAM:
-
Intercellular adhesion molecule
- iE-DAP:
-
γ-D-glutamyl-meso-diaminopimelic acid
- IFI16:
-
IFN-inducible 16
- IFN:
-
Interferon
- IgG:
-
Immunoglobulin G
- IKK:
-
IκB kinase complex
- IL:
-
Interleukin
- ILCs:
-
Innate lymphoid cells
- IRAK:
-
IL-1 receptor-associated kinase protein
- IRF:
-
Interferon regulatory factor
- IRp60:
-
Inhibitory receptor protein
- ISG:
-
IFN-inducible gene
- ITAM:
-
Immunoreceptor tyrosine-based activation motif
- ITIM:
-
Immunoreceptor tyrosine-based inhibitory motifs
- ITSM:
-
Immunoreceptor tyrosine-based switch motifs
- IκB:
-
Inhibitor of nuclear factor kappa B
- JNK:
-
Jun N-terminal kinase
- KACL:
-
Keratinocyte-associated C-type lectin
- KIR:
-
Killer cell immunoglobulin-like receptor
- KLRG1:
-
Killer cell lectin-like receptor G1
- LDL:
-
Low-density lipoproteins
- LFA:
-
Lymphocyte function associated antigen
- LIR:
-
Leukocyte inhibitory receptor
- LMW:
-
Low molecular weight
- LOX-1:
-
Lectin-like oxidized LDL receptor-1
- LPG2:
-
Laboratory of genetics and physiology 2
- LPS:
-
Lipopolysaccharide
- LRR:
-
Leucine-rich repeat
- MAL:
-
MyD88-adaptor-like
- MALT:
-
Mucosa associated lymphoid tissue translocation protein
- MAPK:
-
Mitogen-activated protein kinase
- MAVS:
-
Mitochondrial antiviral signalling protein
- MCL:
-
Macrophage C-type lectin
- MDA5:
-
Melanoma differentiation-associated gene 5
- MDL-1:
-
Myeloid DAP12-associating lectin
- MDP:
-
Muramyl dipeptide
- MEK:
-
MAPK/ERK kinase
- MHC:
-
Major histocompatibility complex
- MICA:
-
MHC class I chain-related A chain
- MICB:
-
MHC class I chain-related B chain
- MICL:
-
Myeloid inhibitory C-type lectin-like receptor
- Mincle:
-
Macrophage-inducible C-type lectin
- MIP:
-
Macrophage inflammatory protein
- MNDA:
-
Myeloid cell nuclear differentiation antigen
- MR:
-
Mannose receptor
- MRE11:
-
Meiotic recombination 11 homolog A
- MTOC:
-
Microtubule organizing centre
- mTOR:
-
Mechanistic target of rapamycin
- MyD88:
-
Myeloid differentiation primary response gene 88
- NAIP:
-
NLR family, apoptosis inhibitory protein
- Nck:
-
Non-catalytic region of tyrosine kinase adaptor protein 1
- ND:
-
Not determined
- NFAT:
-
Nuclear factor of activated T-cells
- NF-κB:
-
Nuclear factor-kappa B
- NIK:
-
NF-κB-inducing kinase
- NK:
-
Natural Killer
- NKG2D:
-
Natural Killer group 2D
- NKR-P1:
-
Killer cell lectin-like receptor subfamily B, member 1
- NLR:
-
NOD-like receptors
- NLRC:
-
NOD-like receptor family CARD domain containing
- NLRP:
-
Nucleotide-binding oligomerization domain, Leucine rich Repeat and Pyrin domain containing
- NOD:
-
Nucleotide-oligomerization domain
- NTB-A:
-
NK, T and B cell antigen
- PAMPs:
-
Pathogen-associated molecular patterns
- PI3K:
-
Phosphoinositide 3-kinase
- PLC-γ:
-
Phospholipase C gamma
- PRRs:
-
Pattern-recognition receptors
- PYD:
-
Pyrin
- PYHIN1:
-
Pyrin and HIN domain-containing protein
- Rac-1:
-
Ras-related C3 botulinum toxin substrate 1
- RANTES:
-
Regulated upon activation, normal T-cell expressed, and secreted
- RICK:
-
RIP-like interacting CLARP kinase
- RIG-1:
-
Retinoic acid-inducible gene-1
- RIP-1:
-
Receptor interacting kinase 1
- RLR:
-
RIG-1-like receptors
- RNA:
-
Ribonucleic acid
- ROS:
-
Reactive oxygen species
- SAP:
-
SLAM-associated protein
- SECTM1:
-
Secreted and transmembrane 1
- SH2:
-
Src homology 2
- SHIP-1:
-
SH2 domain-containing inositol 5′ phosphatase-1
- SHP:
-
Src homology 2 (SH2) domain-containing phosphatases
- SIGNR1:
-
Specific ICAM-3 grabbing nonintegrin-related 1
- SLAM:
-
Signaling lymphocytic activating molecule
- SLP-76:
-
SH2 domain containing leukocyte phosphoprotein of 76 kD
- ssRNA:
-
Single-stranded RNA
- STING:
-
Stimulator of interferon genes
- Syk:
-
Spleen tyrosine kinase
- TAB:
-
TAK1 binding protein
- TAK1:
-
TGF-beta-activated kinase 1
- TBK1:
-
TANK binding kinase 1
- TCR:
-
T cell receptor
- TGF:
-
Transforming growth factor
- TICAM:
-
TIR-domain containing adaptor molecule
- TIR:
-
Toll/IL-1R homology
- TIRAP:
-
TIR-containing adaptor protein
- TLR:
-
Toll-like receptor
- TNF:
-
Tumor necrosis factor
- TNFR:
-
Tumor necrosis factor receptor
- TRADD:
-
TNF receptor-associated death domain
- TRAF:
-
TNFR-associated factor 6
- TRAIL:
-
TNF-related apoptosis-inducing ligand
- TRAM:
-
TRIF-related adaptor molecule
- TRIF:
-
TIR-containing adaptor inducing IFN-β
- ULBP:
-
UL-16 binding protein
- WAS:
-
Wiskott-Aldrich syndrome
- WASP:
-
Wiskott-Aldrich syndrome protein
- WIPF1:
-
WAS/WASL interacting protein family member 1
- XLP:
-
X-linked lymphoproliferative disease
- ZAP70:
-
Zeta-chain-associated protein kinase 70
References
Vivier E, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, Koyasu S, Locksley RM, McKenzie ANJ, Mebius RE, Powrie F, Spits H (2018) Innate lymphoid cells: 10 years on. Cell 174:1054–1066. https://doi.org/10.1016/j.cell.2018.07.017
Takeuchi O, Akira S (2010) Pattern recognition receptors and inflammation. Cell 140:805–820. https://doi.org/10.1016/j.cell.2010.01.022
Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124:783–801. https://doi.org/10.1016/J.CELL.2006.02.015
Vénéreau E, Ceriotti C, Bianchi ME (2015) DAMPs from cell death to new life. Front Immunol 6:422. https://doi.org/10.3389/fimmu.2015.00422
Chen GY, Nuñez G (2010) Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 10:826–837. https://doi.org/10.1038/nri2873
Chen Q, Sun L, Chen ZJ (2016) Regulation and function of the cGAS–STING pathway of cytosolic DNA sensing. Nat Immunol 17:1142–1149. https://doi.org/10.1038/ni.3558
Miguel B, Celeste M, Teresa M (2012) Pathogen strategies to evade innate immune response: a signaling point of view. Protein Kinases. https://doi.org/10.5772/37771
Sancho D, Reis e Sousa C (2012) Signaling by myeloid C-type lectin receptors in immunity and homeostasis. Ann Rev Immunol 30:491–529. https://doi.org/10.1146/annurev-immunol-031210-101352
Kell AM, Gale M (2015) RIG-I in RNA virus recognition. Virology 479–480:110–121. https://doi.org/10.1016/j.virol.2015.02.017
Franchi L, Eigenbrod T, Muñoz-Planillo R, Nuñez G (2009) The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol 10:241–247. https://doi.org/10.1038/ni.1703
Kanneganti T-D, Lamkanfi M, Núñez G (2007) Intracellular NOD-like receptors in host defense and disease. Immunity 27:549–559. https://doi.org/10.1016/j.immuni.2007.10.002
Dey B, Dey RJ, Cheung LS, Pokkali S, Guo H, Lee J-H, Bishai WR (2015) A bacterial cyclic dinucleotide activates the cytosolic surveillance pathway and mediates innate resistance to tuberculosis. Nat Med 21:401–406. https://doi.org/10.1038/nm.3813
Ma Z, Damania B (2016) The cGAS-STINg defense pathway and its counteraction by viruses. Cell Host Microbe 19:150–158. https://doi.org/10.1016/j.chom.2016.01.010
Caruso R, Warner N, Inohara N, Núñez G (2014) NOD1 and NOD2: signaling, host defense, and inflammatory disease. Immunity 41:898–908. https://doi.org/10.1016/j.immuni.2014.12.010
Botos I, Segal DM, Davies DR (2011) The structural biology of Toll-like receptors. Structure 19:447–459. https://doi.org/10.1016/j.str.2011.02.004
Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11:373–384. https://doi.org/10.1038/ni.1863
Kawasaki T, Kawai T (2014) Toll-like receptor signaling pathways. Front Immunol 5:461. https://doi.org/10.3389/fimmu.2014.00461
Lin S-C, Lo Y-C, Wu H (2010) Helical assembly in the MyD88–IRAK4–IRAK2 complex in TLR/IL-1R signalling. Nature 465:885–890. https://doi.org/10.1038/nature09121
Kawagoe T, Sato S, Matsushita K, Kato H, Matsui K, Kumagai Y, Saitoh T, Kawai T, Takeuchi O, Akira S (2008) Sequential control of toll-like receptor–dependent responses by IRAK1 and IRAK2. Nat Immunol 9:684–691. https://doi.org/10.1038/ni.1606
Xia Z-P, Sun L, Chen X, Pineda G, Jiang X, Adhikari A, Zeng W, Chen ZJ (2009) Direct activation of protein kinases by unanchored polyubiquitin chains. Nature 461:114–119. https://doi.org/10.1038/nature08247
Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, Takeuchi O, Sugiyama M, Okabe M, Takeda K, Akira S (2003) Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science (80–) 301:640–643. https://doi.org/10.1126/science.1087262
Oshiumi H, Matsumoto M, Funami K, Akazawa T, Seya T (2003) TICAM-1, an adaptor molecule that participates in Toll-like receptor 3–mediated interferon-β induction. Nat Immunol 4:161–167. https://doi.org/10.1038/ni886
Häcker H, Redecke V, Blagoev B, Kratchmarova I, Hsu L-C, Wang GG, Kamps MP, Raz E, Wagner H, Häcker G, Mann M, Karin M (2006) Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439:204–207. https://doi.org/10.1038/nature04369
Brown GD, Willment JA, Whitehead L (2018) C-type lectins in immunity and homeostasis. Nat Rev Immunol 18:374–389. https://doi.org/10.1038/s41577-018-0004-8
Osorio F, Reis e Sousa C (2011) Myeloid C-type lectin receptors in pathogen recognition and host defense. Immunity 34:651–664. https://doi.org/10.1016/j.immuni.2011.05.001
Kawai T, Akira S (2011) Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34:637–650. https://doi.org/10.1016/J.IMMUNI.2011.05.006
Mócsai A, Ruland J, Tybulewicz VLJ (2010) The SYK tyrosine kinase: a crucial player in diverse biological functions. Nat Rev Immunol 10:387–402. https://doi.org/10.1038/nri2765
Brown GD (2006) Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat Rev Immunol 6:33–43. https://doi.org/10.1038/nri1745
Gross O, Gewies A, Finger K, Schäfer M, Sparwasser T, Peschel C, Förster I, Ruland J (2006) Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature 442:651–656. https://doi.org/10.1038/nature04926
LeibundGut-Landmann S, Gross O, Robinson MJ, Osorio F, Slack EC, Tsoni SV, Schweighoffer E, Tybulewicz V, Brown GD, Ruland J, Reis e Sousa C (2007) Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol 8:630–638. https://doi.org/10.1038/ni1460
Geijtenbeek TBH, Gringhuis SI (2009) Signalling through C-type lectin receptors: shaping immune responses. Nat Rev Immunol 9:465–479. https://doi.org/10.1038/nri2569
Xu S, Huo J, Lee K-G, Kurosaki T, Lam K-P (2009) Phospholipase Cγ2 is critical for Dectin-1-mediated Ca2+ flux and cytokine production in dendritic cells. J Biol Chem 284:7038–7046. https://doi.org/10.1074/jbc.M806650200
Goodridge HS, Simmons RM, Underhill DM (2007) Dectin-1 stimulation by Candida albicans yeast or zymosan triggers NFAT activation in macrophages and dendritic cells. J Immunol 178:3107–3115
Gross O, Poeck H, Bscheider M, Dostert C, Hannesschläger N, Endres S, Hartmann G, Tardivel A, Schweighoffer E, Tybulewicz V, Mocsai A, Tschopp J, Ruland J (2009) Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature 459:433–436. https://doi.org/10.1038/nature07965
Gringhuis SI, den Dunnen J, Litjens M, van der Vlist M, Wevers B, Bruijns SCM, Geijtenbeek TBH (2009) Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-kappaB activation through Raf-1 and Syk. Nat Immunol 10:203–213. https://doi.org/10.1038/ni.1692
Saijo S, Ikeda S, Yamabe K, Kakuta S, Ishigame H, Akitsu A, Fujikado N, Kusaka T, Kubo S, Chung S, Komatsu R, Miura N, Adachi Y, Ohno N, Shibuya K, Yamamoto N, Kawakami K, Yamasaki S, Saito T, Akira S, Iwakura Y (2010) Dectin-2 recognition of alpha-mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans. Immunity 32:681–691. https://doi.org/10.1016/j.immuni.2010.05.001
Robinson MJ, Osorio F, Rosas M, Freitas RP, Schweighoffer E, Groß O, Verbeek JS, Ruland J, Tybulewicz V, Brown GD, Moita LF, Taylor PR, Reis e Sousa C (2009) Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection. J Exp Med 206:2037–2051. https://doi.org/10.1084/jem.20082818
Ritter M, Gross O, Kays S, Ruland J, Nimmerjahn F, Saijo S, Tschopp J, Layland LE, Prazeres da Costa C (2010) Schistosoma mansoni triggers Dectin-2, which activates the Nlrp3 inflammasome and alters adaptive immune responses. Proc Natl Acad Sci USA 107:20459–20464. https://doi.org/10.1073/pnas.1010337107
Chang T-H, Huang J-H, Lin H-C, Chen W-Y, Lee Y-H, Hsu L-C, Netea MG, Ting JP-Y, Wu-Hsieh BA (2017) Dectin-2 is a primary receptor for NLRP3 inflammasome activation in dendritic cell response to Histoplasma capsulatum. PLoS Pathog 13:e1006485. https://doi.org/10.1371/journal.ppat.1006485
Sato K, Yang X, Yudate T, Chung J-S, Wu J, Luby-Phelps K, Kimberly RP, Underhill D, Cruz PD, Ariizumi K (2006) Dectin-2 is a pattern recognition receptor for fungi that couples with the Fc receptor γ chain to induce innate immune responses. J Biol Chem 281:38854–38866. https://doi.org/10.1074/jbc.M606542200
Bi L, Gojestani S, Wu W, Hsu Y-MS, Zhu J, Ariizumi K, Lin X (2010) CARD9 mediates dectin-2-induced IκBα kinase ubiquitination leading to activation of NF-κB in response to stimulation by the hyphal form of Candida albicans. J Biol Chem 285:25969–25977. https://doi.org/10.1074/jbc.M110.131300
Kanazawa N, Okazaki T, Nishimura H, Tashiro K, Inaba K, Miyachi Y (2002) DCIR acts as an inhibitory receptor depending on its immunoreceptor tyrosine-based inhibitory motif. J Invest Dermatol 118:261–266. https://doi.org/10.1046/j.0022-202x.2001.01633.x
Zhao X, Shen Y, Hu W, Chen J, Wu T, Sun X, Yu J, Wu T, Chen W (2015) DCIR negatively regulates CpG-ODN-induced IL-1β and IL-6 production. Mol Immunol 68:641–647. https://doi.org/10.1016/j.molimm.2015.10.007
Meyer-Wentrup F, Cambi A, Joosten B, Looman MW, de Vries IJM, Figdor CG, Adema GJ (2009) DCIR is endocytosed into human dendritic cells and inhibits TLR8-mediated cytokine production. J Leukoc Biol 85:518–525. https://doi.org/10.1189/jlb.0608352
Lambert AA, Barabe F, Gilbert C, Tremblay MJ (2011) DCIR-mediated enhancement of HIV-1 infection requires the ITIM-associated signal transduction pathway. Blood 117:6589–6599. https://doi.org/10.1182/blood-2011-01-331363
Bloem K, Vuist IM, van den Berk M, Klaver EJ, van Die I, Knippels LMJ, Garssen J, García-Vallejo JJ, van Vliet SJ, van Kooyk Y (2014) DCIR interacts with ligands from both endogenous and pathogenic origin. Immunol Lett 158:33–41. https://doi.org/10.1016/j.imlet.2013.11.007
Nagae M, Ikeda A, Hanashima S, Kojima T, Matsumoto N, Yamamoto K, Yamaguchi Y (2016) Crystal structure of human dendritic cell inhibitory receptor C-type lectin domain reveals the binding mode with N-glycan. FEBS Lett 590:1280–1288. https://doi.org/10.1002/1873-3468.12162
Švajger U, Anderluh M, Jeras M, Obermajer N (2010) C-type lectin DC-SIGN: an adhesion, signalling and antigen-uptake molecule that guides dendritic cells in immunity. Cell Signal 22:1397–1405. https://doi.org/10.1016/j.cellsig.2010.03.018
Gringhuis SI, den Dunnen J, Litjens M, van het Hof B, van Kooyk Y, Geijtenbeek TBH (2007) C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-κB. Immunity 26:605–616. https://doi.org/10.1016/j.immuni.2007.03.012
Gringhuis SI, den Dunnen J, Litjens M, van der Vlist M, Geijtenbeek TBH (2009) Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori. Nat Immunol 10:1081–1088. https://doi.org/10.1038/ni.1778
Hovius JWR, de Jong MAWP, den Dunnen J, Litjens M, Fikrig E, van der Poll T, Gringhuis SI, Geijtenbeek TBH (2008) Salp15 binding to DC-SIGN inhibits cytokine expression by impairing both nucleosome remodeling and mRNA stabilization. PLoS Pathog 4:e31. https://doi.org/10.1371/journal.ppat.0040031
Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T (2004) The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5:730–737. https://doi.org/10.1038/ni1087
Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, Ishii KJ, Takeuchi O, Akira S (2005) IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 6:981–988. https://doi.org/10.1038/ni1243
Dixit E, Boulant S, Zhang Y, Lee ASY, Odendall C, Shum B, Hacohen N, Chen ZJ, Whelan SP, Fransen M, Nibert ML, Superti-Furga G, Kagan JC (2010) Peroxisomes are signaling platforms for antiviral innate immunity. Cell 141:668–681. https://doi.org/10.1016/j.cell.2010.04.018
Seth RB, Sun L, Ea C-K, Chen ZJ (2005) Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122:669–682. https://doi.org/10.1016/j.cell.2005.08.012
Takahashi K, Kawai T, Kumar H, Sato S, Yonehara S, Akira S (2006) Roles of caspase-8 and caspase-10 in innate immune responses to double-stranded RNA. J Immunol 176:4520–4524
Poeck H, Bscheider M, Gross O, Finger K, Roth S, Rebsamen M, Hannesschläger N, Schlee M, Rothenfusser S, Barchet W, Kato H, Akira S, Inoue S, Endres S, Peschel C, Hartmann G, Hornung V, Ruland J (2010) Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1β production. Nat Immunol 11:63–69. https://doi.org/10.1038/ni.1824
Satoh T, Kato H, Kumagai Y, Yoneyama M, Sato S, Matsushita K, Tsujimura T, Fujita T, Akira S, Takeuchi O (2010) LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses. Proc Natl Acad Sci 107:1512–1517. https://doi.org/10.1073/pnas.0912986107
Chamaillard M, Hashimoto M, Horie Y, Masumoto J, Qiu S, Saab L, Ogura Y, Kawasaki A, Fukase K, Kusumoto S, Valvano MA, Foster SJ, Mak TW, Nuñez G, Inohara N (2003) An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat Immunol 4:702–707. https://doi.org/10.1038/ni945
Hasegawa M, Yang K, Hashimoto M, Park J-H, Kim Y-G, Fujimoto Y, Nuñez G, Fukase K, Inohara N (2006) Differential release and distribution of Nod1 and Nod2 immunostimulatory molecules among bacterial species and environments. J Biol Chem 281:29054–29063. https://doi.org/10.1074/jbc.M602638200
Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, Thomas G, Philpott DJ, Sansonetti PJ (2003) Nod2 is a general sensor of peptidoglycan through Muramyl Dipeptide (MDP) detection. J Biol Chem 278:8869–8872. https://doi.org/10.1074/jbc.C200651200
Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, Nunez G (2001) Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-κB. J Biol Chem 276:4812–4818. https://doi.org/10.1074/jbc.M008072200
Windheim M, Lang C, Peggie M, Plater LA, Cohen P (2007) Molecular mechanisms involved in the regulation of cytokine production by muramyl dipeptide. Biochem J 404:179–190. https://doi.org/10.1042/BJ20061704
Girardin SE, Tournebize R, Mavris M, Page AL, Li X, Stark GR, Bertin J, DiStefano PS, Yaniv M, Sansonetti PJ, Philpott DJ (2001) CARD4/Nod1 mediates NF-κB and JNK activation by invasive Shigella flexneri. EMBO Rep 2:736–742. https://doi.org/10.1093/embo-reports/kve155
Park J-H, Kim Y-G, McDonald C, Kanneganti T-D, Hasegawa M, Body-Malapel M, Inohara N, Núñez G (2007) RICK/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs. J Immunol 178:2380–2386
Mariathasan S, Weiss DS, Newton K, McBride J, O’Rourke K, Roose-Girma M, Lee WP, Weinrauch Y, Monack DM, Dixit VM (2006) Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440:228–232. https://doi.org/10.1038/nature04515
Mariathasan S, Newton K, Monack DM, Vucic D, French DM, Lee WP, Roose-Girma M, Erickson S, Dixit VM (2004) Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430:213–218. https://doi.org/10.1038/nature02664
Lugrin J, Martinon F (2018) The AIM2 inflammasome: sensor of pathogens and cellular perturbations. Immunol Rev 281:99–114. https://doi.org/10.1111/imr.12618
Hornung V, Ablasser A, Charrel-Dennis M, Bauernfeind F, Horvath G, Caffrey DR, Latz E, Fitzgerald KA (2009) AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458:514–518. https://doi.org/10.1038/nature07725
Fernandes-Alnemri T, Yu J-W, Datta P, Wu J, Alnemri ES (2009) AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458:509–513. https://doi.org/10.1038/nature07710
Kerur N, Veettil MV, Sharma-Walia N, Bottero V, Sadagopan S, Otageri P, Chandran B (2011) IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi Sarcoma-associated herpesvirus infection. Cell Host Microbe 9:363–375. https://doi.org/10.1016/j.chom.2011.04.008
Unterholzner L, Keating SE, Baran M, Horan KA, Jensen SB, Sharma S, Sirois CM, Jin T, Latz E, Xiao TS, Fitzgerald KA, Paludan SR, Bowie AG (2010) IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol 11:997–1004. https://doi.org/10.1038/ni.1932
Ishikawa H, Ma Z, Barber GN (2009) STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461:788–792. https://doi.org/10.1038/nature08476
Ablasser A, Goldeck M, Cavlar T, Deimling T, Witte G, Röhl I, Hopfner K-P, Ludwig J, Hornung V (2013) cGAS produces a 2′-5′-linked cyclic dinucleotide second messenger that activates STING. Nature 498:380–384. https://doi.org/10.1038/nature12306
Schoggins JW, MacDuff DA, Imanaka N, Gainey MD, Shrestha B, Eitson JL, Mar KB, Richardson RB, Ratushny AV, Litvak V, Dabelic R, Manicassamy B, Aitchison JD, Aderem A, Elliott RM, García-Sastre A, Racaniello V, Snijder EJ, Yokoyama WM, Diamond MS, Virgin HW, Rice CM (2014) Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature 505:691–695. https://doi.org/10.1038/nature12862
Saitoh T, Fujita N, Hayashi T, Takahara K, Satoh T, Lee H, Matsunaga K, Kageyama S, Omori H, Noda T, Yamamoto N, Kawai T, Ishii K, Takeuchi O, Yoshimori T, Akira S (2009) Atg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response. Proc Natl Acad Sci USA 106:20842–20846. https://doi.org/10.1073/pnas.0911267106
Sun W, Li Y, Chen L, Chen H, You F, Zhou X, Zhou Y, Zhai Z, Chen D, Jiang Z (2009) ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization. Proc Natl Acad Sci USA 106:8653–8658. https://doi.org/10.1073/pnas.0900850106
Liu S, Cai X, Wu J, Cong Q, Chen X, Li T, Du F, Ren J, Wu Y-T, Grishin NV, Chen ZJ (2015) Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science 347:aaa2630. https://doi.org/10.1126/science.aaa2630
Ishikawa H, Barber GN (2008) STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455:674–678. https://doi.org/10.1038/nature07317
Collins AC, Cai H, Li T, Franco LH, Li X-D, Nair VR, Scharn CR, Stamm CE, Levine B, Chen ZJ, Shiloh MU (2015) Cyclic GMP-AMP synthase is an innate immune DNA sensor for Mycobacterium tuberculosis. Cell Host Microbe 17:820–828. https://doi.org/10.1016/j.chom.2015.05.005
Woodward JJ, Iavarone AT, Portnoy DA (2010) c-di-AMP secreted by intracellular listeria monocytogenes activates a host type I interferon response. Science (80–) 328:1703–1705. https://doi.org/10.1126/science.1189801
Moretti J, Roy S, Bozec D, Martinez J, Chapman JR, Ueberheide B, Lamming DW, Chen ZJ, Horng T, Yeretssian G, Green DR, Blander JM (2017) STING senses microbial viability to orchestrate stress-mediated autophagy of the endoplasmic reticulum. Cell 171:809–823.e13. https://doi.org/10.1016/j.cell.2017.09.034
Burdette DL, Monroe KM, Sotelo-Troha K, Iwig JS, Eckert B, Hyodo M, Hayakawa Y, Vance RE (2011) STING is a direct innate immune sensor of cyclic di-GMP. Nature 478:515–518. https://doi.org/10.1038/nature10429
Orange JS, Ballas ZK (2006) Natural killer cells in human health and disease. Clin Immunol 118:1–10
Biron CA, Byron KS, Sullivan JL (1989) Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med 320:1731–1735
Orange JS (2002) Human natural killer cell deficiencies and susceptibility to infection. Microbes Infect 4:1545–1558
Voskoboinik I, Smyth MJ, Trapani JA (2006) Perforin-mediated target-cell death and immune homeostasis. Nat Rev Immunol 6:940–952
Wallin RP, Screpanti V, Michaelsson J, Grandien A, Ljunggren HG (2003) Regulation of perforin-independent NK cell-mediated cytotoxicity. Eur J Immunol 33:2727–2735
Boehm U, Klamp T, Groot M, Howard JC (1997) Cellular responses to interferon-γ. Ann Rev Immunol 15:749–795
Orange JS, Harris KE, Andzelm MM, Valter MM, Geha RS, Strominger JL (2003) The mature activating natural killer cell immunologic synapse is formed in distinct stages. Proc Natl Acad Sci USA 100:14151–14156
Wulfing C, Purtic B, Klem J, Schatzle JD (2003) Stepwise cytoskeletal polarization as a series of checkpoints in innate but not adaptive cytolytic killing. Proc Natl Acad Sci USA 100:7767–7772
Bryceson YT, March ME, Ljunggren HG, Long EO (2006) Activation, coactivation, and costimulation of resting human natural killer cells. Immunol Rev 214:273–291
Carpen O, Virtanen I, Saksela E (1982) Ultrastructure of human natural killer cells: nature of the cytolytic contacts in relation to cellular secretion. J Immunol 128:2691–2697
Carpen O, Virtanen I, Lehto VP, Saksela E (1983) Polarization of NK cell cytoskeleton upon conjugation with sensitive target cells. J Immunol 131:2695–2698
Kupfer A, Dennert G, Singer SJ (1983) Polarization of the Golgi apparatus and the microtubule-organizing center within cloned natural killer cells bound to their targets. Proc Natl Acad Sci USA 80:7224–7228
Bossi G, Griffiths GM (2005) CTL secretory lysosomes: biogenesis and secretion of a harmful organelle. Semin Immunol 17:87–94
Eriksson M, Leitz G, Fallman E, Axner O, Ryan JC, Nakamura MC, Sentman CL (1999) Inhibitory receptors alter natural killer cell interactions with target cells yet allow simultaneous killing of susceptible targets. J Exp Med 190:1005–1012
Bryceson YT, March ME, Barber DF, Ljunggren HG, Long EO (2005) Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells. J Exp Med 202:1001–1012
Long EO, Kim HS, Liu D, Peterson ME, Rajagopalan S (2013) Controlling natural killer cell responses: integration of signals for activation and inhibition. Ann Rev Immunol 31:227–258. https://doi.org/10.1146/annurev-immunol-020711-075005
Moretta L, Moretta A (2004) Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J 23:255–259. https://doi.org/10.1038/sj.emboj.7600019
Lanier LL (2005) NK cell recognition. Ann Rev Immunol 23:225–274. https://doi.org/10.1146/annurev.immunol.23.021704.115526
Smith-Garvin JE, Koretzky GA, Jordan MS (2009) T cell activation. Ann Rev Immunol 27:591–619. https://doi.org/10.1146/annurev.immunol.021908.132706
Kim HS, Long EO (2012) Complementary phosphorylation sites in the adaptor protein SLP-76 promote synergistic activation of natural killer cells. Sci Signal 5:ra49. https://doi.org/10.1126/scisignal.2002754
Wu J, Song Y, Bakker AB, Bauer S, Spies T, Lanier LL, Phillips JH (1999) An activating immunoreceptor complex formed by NKG2D and DAP10. Science (80–) 285:730–732
Gilfillan S, Ho EL, Cella M, Yokoyama WM, Colonna M (2002) NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation. Nat Immunol 3:1150–1155. https://doi.org/10.1038/ni857
Billadeau DD, Upshaw JL, Schoon RA, Dick CJ, Leibson PJ (2003) NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway. Nat Immunol 4:557–564. https://doi.org/10.1038/ni929
Graham DB, Cella M, Giurisato E, Fujikawa K, Miletic AV, Kloeppel T, Brim K, Takai T, Shaw AS, Colonna M, Swat W (2006) Vav1 controls DAP10-mediated natural cytotoxicity by regulating actin and microtubule dynamics. J Immunol 177:2349–2355
Upshaw JL, Arneson LN, Schoon RA, Dick CJ, Billadeau DD, Leibson PJ (2006) NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells. Nat Immunol 7:524–532. https://doi.org/10.1038/ni1325
Segovis CM, Schoon RA, Dick CJ, Nacusi LP, Leibson PJ, Billadeau DD (2009) PI3K links NKG2D signaling to a CrkL pathway involved in natural killer cell adhesion, polarity, and granule secretion. J Immunol 182:6933–6942. https://doi.org/10.4049/jimmunol.0803840
Veillette A (2006) NK cell regulation by SLAM family receptors and SAP-related adapters. Immunol Rev 214:22–34. https://doi.org/10.1111/j.1600-065X.2006.00453.x
Dong Z, Cruz-Munoz ME, Zhong MC, Chen R, Latour S, Veillette A (2009) Essential function for SAP family adaptors in the surveillance of hematopoietic cells by natural killer cells. Nat Immunol 10:973–980. https://doi.org/10.1038/ni.1763
Shibuya K, Lanier LL, Phillips JH, Ochs HD, Shimizu K, Nakayama E, Nakauchi H, Shibuya A (1999) Physical and functional association of LFA-1 with DNAM-1 adhesion molecule. Immunity 11:615–623
Dennehy KM, Klimosch SN, Steinle A (2011) Cutting edge: NKp80 uses an atypical hemi-ITAM to trigger NK cytotoxicity. J Immunol 186:657–661. https://doi.org/10.4049/jimmunol.0904117
Nurmi SM, Autero M, Raunio AK, Gahmberg CG, Fagerholm SC (2007) Phosphorylation of the LFA-1 integrin beta2-chain on Thr-758 leads to adhesion, Rac-1/Cdc42 activation, and stimulation of CD69 expression in human T cells. J Biol Chem 282:968–975
March ME, Long EO (2011) beta2 integrin induces TCRzeta-Syk-phospholipase C-gamma phosphorylation and paxillin-dependent granule polarization in human NK cells. J Immunol 186:2998–3005. https://doi.org/10.4049/jimmunol.1002438
Riteau B, Barber DF, Long EO (2003) Vav1 phosphorylation is induced by beta2 integrin engagement on natural killer cells upstream of actin cytoskeleton and lipid raft reorganization. J Exp Med 198:469–474
Stebbins CC, Watzl C, Billadeau DD, Leibson PJ, Burshtyn DN, Long EO (2003) Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity. Mol Cell Biol 23:6291–6299
Vyas YM, Mehta KM, Morgan M, Maniar H, Butros L, Jung S, Burkhardt JK, Dupont B (2001) Spatial organization of signal transduction molecules in the NK cell immune synapses during MHC class I-regulated noncytolytic and cytolytic interactions. J Immunol 167:4358–4367
Vyas YM, Maniar H, Dupont B (2002) Cutting edge: differential segregation of the SRC homology 2-containing protein tyrosine phosphatase-1 within the early NK cell immune synapse distinguishes noncytolytic from cytolytic interactions. J Immunol 168:3150–3154
McCann FE, Vanherberghen B, Eleme K, Carlin LM, Newsam RJ, Goulding D, Davis DM (2003) The size of the synaptic cleft and distinct distributions of filamentous actin, ezrin, CD43, and CD45 at activating and inhibitory human NK cell immune synapses. J Immunol 170:2862–2870
Braud V, Jones EY, McMichael A (1997) The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur J Immunol 27:1164–1169
Valiante NM, Uhrberg M, Shilling HG, Lienert-Weidenbach K, Arnett KL, D’Andrea A, Phillips JH, Lanier LL, Parham P (1997) Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 7:739–751
Parham P (2005) MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 5:201–214
MacFarlane AW 4th, Campbell KS (2006) Signal transduction in natural killer cells. Curr Top Microbiol Immunol 298:23–57
Binstadt BA, Billadeau DD, Jevremovic D, Williams BL, Fang N, Yi T, Koretzky GA, Abraham RT, Leibson PJ (1998) SLP-76 is a direct substrate of SHP-1 recruited to killer cell inhibitory receptors. J Biol Chem 273:27518–27523
Peterson ME, Long EO (2008) Inhibitory receptor signaling via tyrosine phosphorylation of the adaptor Crk. Immunity 29:578–588. https://doi.org/10.1016/j.immuni.2008.07.014
Liu D, Peterson ME, Long EO (2012) The adaptor protein Crk controls activation and inhibition of natural killer cells. Immunity 36:600–611. https://doi.org/10.1016/j.immuni.2012.03.007
Ljunggren HG, Karre K (1990) In search of the “missing self”: MHC molecules and NK cell recognition. Immunol Today 11:237–244
Almeida CR, Davis DM (2006) Segregation of HLA-C from ICAM-1 at NK cell immune synapses is controlled by its cell surface density. J Immunol 177:6904–6910
Kaplan A, Kotzer S, Almeida CR, Kohen R, Halpert G, Salmon-Divon M, Kohler K, Hoglund P, Davis DM, Mehr R (2011) Simulations of the NK cell immune synapse reveal that activation thresholds can be established by inhibitory receptors acting locally. J Immunol 187:760–773. https://doi.org/10.4049/jimmunol.1002208
Endt J, McCann FE, Almeida CR, Urlaub D, Leung R, Pende D, Davis DM, Watzl C (2007) Inhibitory receptor signals suppress ligation-induced recruitment of NKG2D to GM1-rich membrane domains at the human NK cell immune synapse. J Immunol 178:5606–5611
Oszmiana A, Williamson DJ, Cordoba SP, Morgan DJ, Kennedy PR, Stacey K, Davis DM (2016) The size of activating and inhibitory killer Ig-like receptor nanoclusters is controlled by the transmembrane sequence and affects signaling. Cell Rep 15:1957–1972. https://doi.org/10.1016/j.celrep.2016.04.075
von Bernuth H, Picard C, Jin Z, Pankla R, Xiao H, Ku C-L, Chrabieh M, Mustapha IB, Ghandil P, Camcioglu Y, Vasconcelos J, Sirvent N, Guedes M, Vitor AB, Herrero-Mata MJ, Arostegui JI, Rodrigo C, Alsina L, Ruiz-Ortiz E, Juan M, Fortuny C, Yague J, Anton J, Pascal M, Chang H-H, Janniere L, Rose Y, Garty B-Z, Chapel H, Issekutz A, Marodi L, Rodriguez-Gallego C, Banchereau J, Abel L, Li X, Chaussabel D, Puel A, Casanova J-L (2008) Pyogenic Bacterial Infections in humans with MyD88 deficiency. Science (80–) 321:691–696. https://doi.org/10.1126/science.1158298
Hawn TR, Verbon A, Lettinga KD, Zhao LP, Li SS, Laws RJ, Skerrett SJ, Beutler B, Schroeder L, Nachman A, Ozinsky A, Smith KD, Aderem A (2003) A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires’ disease. J Exp Med 198:1563–1572. https://doi.org/10.1084/jem.20031220
Lorenz E, Mira JP, Frees KL, Schwartz DA (2002) Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med 162:1028–1032
Ferwerda B, Ferwerda G, Plantinga TS, Willment JA, van Spriel AB, Venselaar H, Elbers CC, Johnson MD, Cambi A, Huysamen C, Jacobs L, Jansen T, Verheijen K, Masthoff L, Morré SA, Vriend G, Williams DL, Perfect JR, Joosten LAB, Wijmenga C, van der Meer JWM, Adema GJ, Kullberg BJ, Brown GD, Netea MG (2009) Human Dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med 361:1760–1767. https://doi.org/10.1056/NEJMoa0901053
Glocker E-O, Hennigs A, Nabavi M, Schäffer AA, Woellner C, Salzer U, Pfeifer D, Veelken H, Warnatz K, Tahami F, Jamal S, Manguiat A, Rezaei N, Amirzargar AA, Plebani A, Hannesschläger N, Gross O, Ruland J, Grimbacher B (2009) A Homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med 361:1727–1735. https://doi.org/10.1056/NEJMoa0810719
Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD (2001) Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 29:301–305. https://doi.org/10.1038/ng756
Aksentijevich I, Nowak M, Mallah M, Chae JJ, Watford WT, Hofmann SR, Stein L, Russo R, Goldsmith D, Dent P, Rosenberg HF, Austin F, Remmers EF, Balow JE, Rosenzweig S, Komarow H, Shoham NG, Wood G, Jones J, Mangra N, Carrero H, Adams BS, Moore TL, Schikler K, Hoffman H, Lovell DJ, Lipnick R, Barron K, O’Shea JJ, Kastner DL, Goldbach-Mansky R (2002) De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum 46:3340–3348. https://doi.org/10.1002/art.10688
Aganna E, Martinon F, Hawkins PN, Ross JB, Swan DC, Booth DR, Lachmann HJ, Bybee A, Gaudet R, Woo P, Feighery C, Cotter FE, Thome M, Hitman GA, Tschopp J, McDermott MF (2002) Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis Rheum 46:2445–2452. https://doi.org/10.1002/art.10509
Rodero MP, Crow YJ (2016) Type I interferon-mediated monogenic autoinflammation: the type I interferonopathies, a conceptual overview. J Exp Med 213:2527–2538. https://doi.org/10.1084/jem.20161596
Liu Y, Jesus AA, Marrero B, Yang D, Ramsey SE, Montealegre Sanchez GA, Goldbach-Mansky R et al (2014) Activated STING in a vascular and pulmonary syndrome. N Engl J Med 371:507–518. https://doi.org/10.1056/NEJMoa1312625
Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar J-P, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nuñez G, Cho JH (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 411:603–606. https://doi.org/10.1038/35079114
Hugot J-P, Chamaillard M, Zouali H, Lesage S, Cézard J-P, Belaiche J, Almer S, Tysk C, O’Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel J-F, Sahbatou M, Thomas G (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 411:599–603. https://doi.org/10.1038/35079107
McGovern DPB, Hysi P, Ahmad T, van Heel DA, Moffatt MF, Carey A, Cookson WOC, Jewell DP (2005) Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease. Hum Mol Genet 14:1245–1250. https://doi.org/10.1093/hmg/ddi135
Orange JS (2014) Natural killer cell deficiency. J Allergy Clin Immunol 132:515–525. https://doi.org/10.1016/j.jaci.2013.07.020
Orange JS, Ramesh N, Remold-O’Donnell E, Sasahara Y, Koopman L, Byrne M, Bonilla FA, Rosen FS, Geha RS, Strominger JL (2002) Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses. Proc Natl Acad Sci 99:11351–11356. https://doi.org/10.1073/pnas.162376099
Lanzi G, Moratto D, Vairo D, Masneri S, Delmonte O, Paganini T, Parolini S, Tabellini G, Mazza C, Savoldi G, Montin D, Martino S, Tovo P, Pessach IM, Massaad MJ, Ramesh N, Porta F, Plebani A, Notarangelo LD, Geha RS, Giliani S (2012) A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP. J Exp Med 209:29–34. https://doi.org/10.1084/jem.20110896
Mace EM (2018) Phosphoinositide-3-kinase signaling in human natural killer cells: new insights from primary immunodeficiency. Front Immunol 9:7–10. https://doi.org/10.3389/fimmu.2018.00445
Lucas CL, Kuehn HS, Zhao F, Niemela JE, Deenick EK, Palendira U, Avery DT, Moens L, Cannons JL, Biancalana M, Stoddard J, Ouyang W, Frucht DM, Rao VK, Atkinson TP, Agharahimi A, Hussey AA, Folio LR, Olivier KN, Fleisher TA, Pittaluga S, Holland SM, Cohen JI, Oliveira JB, Tangye SG, Schwartzberg PL, Lenardo MJ, Uzel G (2014) Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency. Nat Immunol 15:88–97. https://doi.org/10.1038/ni.2771
Angulo I, Vadas O, Garçon F, Banham-Hall E, Plagnol V, Leahy TR, Baxendale H, Coulter T, Curtis J, Wu C, Blake-Palmer K, Perisic O, Smyth D, Maes M, Fiddler C, Juss J, Cilliers D, Markelj G, Chandra A, Farmer G, Kielkowska A, Clark J, Kracker S, Debré M, Picard C, Pellier I, Jabado N, Morris JA, Barcenas-Morales G, Fischer A, Stephens L, Hawkins P, Barrett JC, Abinun M, Clatworthy M, Durandy A, Doffinger R, Chilvers ER, Cant AJ, Kumararatne D, Okkenhaug K, Williams RL, Condliffe A, Nejentsev S (2013) Phosphoinositide 3-kinase δ gene mutation predisposes to respiratory infection and airway damage. Science 342:866–871. https://doi.org/10.1126/science.1243292
Ruiz-García R, Vargas-Hernández A, Chinn IK, Angelo LS, Cao TN, Coban-Akdemir Z, Jhangiani SN, Meng Q, Forbes LR, Muzny DM, Allende LM, Ehlayel MS, Gibbs RA, Lupski JR, Uzel G, Orange JS, Mace EM (2018) Mutations in PI3K110δ cause impaired natural killer cell function partially rescued by rapamycin treatment. J Allergy Clin Immunol 142:605–617.e7. https://doi.org/10.1016/j.jaci.2017.11.042
Benoit L, Wang X, Pabst HF, Dutz J, Tan R (2000) Defective NK cell activation in X-linked lymphoproliferative disease. J Immunol 165:3549–3553
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Neves, B.M., Almeida, C.R. (2020). Signaling Pathways Governing Activation of Innate Immune Cells. In: Silva, J.V., Freitas, M.J., Fardilha, M. (eds) Tissue-Specific Cell Signaling. Springer, Cham. https://doi.org/10.1007/978-3-030-44436-5_4
Download citation
DOI: https://doi.org/10.1007/978-3-030-44436-5_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-44435-8
Online ISBN: 978-3-030-44436-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)